Tizanidne Hydrochloride Capsule
Product Images NDC 71335-2077

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Tizanidne Hydrochloride (NDC 71335-2077). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label (Lbl713352077)

Label (Lbl713352077)
This is a description for a medicine package of Zanaflex 6mg Capsule with Alkem Laboratories Ltd. as the manufacturer. It contains 30 capsules with an expiration date of MM/YY and an NDC code of 7133520771. The medicine should be stored at room temperature between 20°-25°C (68°-77°F) and may cause drowsiness. The package was prepacked by Bryant Ranck.*
FDA Label Image

Tiz01 (Tiz01)

FDA Label Image

Tiz02 (Tiz02)

FDA Label Image

Tiz03 (Tiz03)

FDA Label Image

Tiz04 (Tiz04)

Tiz04 (Tiz04)
This text presents the results of a study evaluating the improvement in Ashworth Score after treatment with Tizanidine. The mean dose used in the study was 26.8 mg. The study lasted for 7 weeks, with the end of titration occurring in week 3 and the endpoint being the last observation carried forward. The results are presented in the form of a table with 2 T's indicating improvement in Ashworth Score at the different stages of the study.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.